文献速递临床免疫质量管理与危急值

基于检索的HEp-2间接免疫荧光AC-2/AC-30自动判别系统的开发与临床验证

Automated ICAP AC-30/AC-2 discrimination on HEp-2 indirect immunofluorescence: development and clinical validation of a retrieval-based diagnostic system.
PubMed 文献 · Clin Chim Acta · 2026-04-22

本研究开发了一种基于检索的诊断软件模块,用于在已确认有丝分裂板阳性的标本中区分AC-2核致密细斑点型与AC-30核细斑点型。模块在557例回顾性队列中开发,并在103例前瞻性临床队列中独立验证,最佳配置在内部留出验证集上总体准确率达95.1%,AC-30精确率100%、召回率90.6%,无假阳性AC-30分配,且每次预测附带检索参考图像以提供可解释证据。

要点

  • 基于检索的模块可高精度区分AC-2与AC-30,AC-30精确率100%。
  • 检索式设计提升AC-30精确率与重复运行可重复性。
  • 每次预测附带参考图像,支持实验室质量保证与审核。

核心结论

  • 基于检索的诊断模块在更新ICAP命名下实现了专家级AC-2/AC-30区分,提高类别精确率并保持可重复性与可解释性。
  • 向量数据库设计支持增量更新而无需重新训练,便于临床实验室在ICAP标准演进中实际部署。

研究设计与样本

  • 开发检索式诊断软件模块,集成MaxViT编码器与Milvus向量数据库,用于有丝分裂板阳性标本的二阶段AC-2/AC-30区分。
  • 在557例回顾性队列中开发,并在来自三级转诊中心的103例前瞻性临床队列中独立验证。
  • 比较六种编码器架构在softmax分类与基于相似度检索两种方式下的性能。

主要发现

  • 最佳配置在内部留出验证集上总体准确率95.1%,AC-30精确率100%、召回率90.6%,无假阳性AC-30分配。
  • 基于相似度检索在所有评估架构中一致提升AC-30精确率,并在重复运行中展现增强的可重复性。
  • 每次预测均附带一张检索到的参考图像,提供可解释且可审核的证据链。

临床怎么用

  • 可作为辅助工具支持专家对AC-2/AC-30的解读,而非替代临床决策。
  • 检索参考图像可用于实验室质量保证与结果审核。
  • 向量数据库设计支持随ICAP标准更新而增量更新,无需重新训练。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate discrimination between the AC-2 nuclear dense fine speckled pattern and the AC-30 nuclear fine speckled pattern with mitotic plate on HEp-2 indirect immunofluorescence is required for ICAP-compliant reporting but remains technically challenging. The 7th ICAP workshop established AC-30 as a distinct entity. Current automated systems operate at the competent level and do not address this expert-level distinction. In addition, the clinical interpretation of AC-2 depends on the complete autoantibody profile rather than pattern morphology alone, underscoring the need for precise and standardized pattern recognition. METHODS: We developed a retrieval-based diagnostic software module for second-stage AC-2 and AC-30 discrimination in specimens with confirmed mitotic plate positivity. The module integrates a MaxViT encoder with a Milvus vector database. It was developed on a retrospective cohort of 557 cases and independently validated on a prospective clinical cohort of 103 cases from a tertiary referral center. Performance was compared across six encoder architectures using both softmax classification and similarity-based retrieval. RESULTS: The optimal configuration achieved 95.1% overall accuracy on the internal hold-out validation set, with 100% precision and 90.6% recall for AC-30, resulting in no false-positive AC-30 assignments. Similarity-based retrieval consistently improved AC-30 precision across all evaluated architectures and demonstrated enhanced reproducibility across repeated runs. Each prediction was accompanied by a retrieved reference image, providing an interpretable and auditable evidence trail for laboratory quality assurance. CONCLUSION: This study presents a validated retrieval-based diagnostic software module for expert-level AC-2/AC-30 discrimination under updated ICAP nomenclature. The system improves class-specific precision while maintaining reproducibility and interpretability. Its vector database design enables incremental updates without retraining, supporting practical implementation in clinical laboratories as ICAP standards evolve. The module is designed as an assistive tool to support expert interpretation rather than replace clinical decision making.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Wu C, Fang K, Li C, et al. Automated ICAP AC-30/AC-2 discrimination on HEp-2 indirect immunofluorescence: development and clinical validation of a retrieval-based diagnostic system. Clin Chim Acta. 2026. PMID: 42031356. doi:10.1016/j.cca.2026.121031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。